Computational solvent mapping in structure-based drug design

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Ciulli A, Williams G, Smith AG, Blundell TL, Abell C. Probing hot spots at protein-ligand binding sites: a fragment-based approach using biophysical methods. J. Med. Chem. 49(16), 4992–5000 (2006).
  Medline CASGoogle Scholar
• 2 Shuker SB, Hajduk PJ, Meadows RP, Fesik SW. Discovering high-affinity ligands for proteins: SAR by NMR. Science 274(5292), 1531–1534 (1996).
  Medline CASGoogle Scholar
• 3 Hajduk PJ, Huth JR, Fesik SW. Druggability indices for protein targets derived from NMR-based screening data. J. Med. Chem. 48(7), 2518–2525 (2005).
  Medline CASGoogle Scholar
• 4 Hajduk PJ, Huth JR, Tse C. Predicting protein druggability. Drug Discov. Today 10(23–24), 1675–1682 (2005).
  Medline CASGoogle Scholar
• 5 Ngan CH, Hall DR, Zerbe B, Grove LE, Kozakov D, Vajda S. FTSite: high accuracy detection of ligand binding sites on unbound protein structures. Bioinformatics 28(2), 286–287 (2012).
  Medline CASGoogle Scholar
• 6 Michelotti EL, Moffett KK, Nguyen D et al. Two classes of p38α MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes. Bioorg. Med. Chem. Lett. 15(23), 5274–5279 (2005).
  Medline CASGoogle Scholar
• 7 Moffett K, Konteatis Z, Nguyen D et al. Discovery of a novel class of non-ATP site DFG-out state p38 inhibitors utilizing computationally assisted virtual fragment-based drug design (vFBDD). Bioorg. Med. Chem. Lett. 21(23), 7155–7165 (2011).
  Medline CASGoogle Scholar
• 8 Itzstein von M, Wu W-Y, Kok GB et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363(6428), 418–423 (1993).
  MedlineGoogle Scholar
• 9 Itzstein von M, Dyason JC, Oliver SW et al. A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs. J. Med. Chem. 39(2), 388–391 (1996).
  MedlineGoogle Scholar
• 10 Schubert CR, Stultz CM. The multi-copy simultaneous search methodology: a fundamental tool for structure-based drug design. J. Comput. Aided Mol. Des. 23(8), 475–489 (2009).• Thorough review of multiple copy simultaneous search and its applications.
  Medline CASGoogle Scholar
• 11 Joseph-McCarthy D, Alvarez JC. Automated generation of MCSS‐derived pharmacophoric DOCK site points for searching multiconformation databases. Proteins 51(2), 189–202 (2003).
  Medline CASGoogle Scholar
• 12 Joseph-McCarthy D, Tsang SK, Filman DJ, Hogle JM, Karplus M. Use of MCSS to design small targeted libraries: application to picornavirus ligands. J. Am. Chem. Soc. 123(51), 12758–12769 (2001).
  Medline CASGoogle Scholar
• 13 Silberstein M, Landon MR, Wang YE, Perl A, Vajda S. Computational methods for functional site identification suggest a substrate access channel in transaldolase. Genome Inform. 17(1), 13–22 (2006).
  Medline CASGoogle Scholar
• 14 Landon MR, Amaro RE, Baron R et al. Novel druggable hot spots in avian influenza neuraminidase h5n1 revealed by computational solvent mapping of a reduced and representative receptor ensemble. Chem. Biol. Drug Des. 71(2), 106–116 (2008).
  Medline CASGoogle Scholar
• 15 Sheu S-H, Kaya T, Waxman DJ, Vajda S. Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping. Biochemistry 44(4), 1193–1209 (2005).
  Medline CASGoogle Scholar
• 16 Hall DR, Ngan CH, Zerbe B, Kozakov D, Vajda S. Hot spot analysis for driving the development of hits into leads in fragment-based drug discovery. J. Chem. Inf. Model 52(1), 199–209 (2011).
  MedlineGoogle Scholar
• 17 Villar EA, Beglov D, Chennamadhavuni S et al. How proteins bind macrocycles. Nat. Chem. Biol. 10(9), 723–731 (2014).
  Medline CASGoogle Scholar
• 18 FTMap ftmap.bu.edu.
  Google Scholar
• 19 FTFlex ftflex.bu.edu.
  Google Scholar
• 20 National Biomedical Computation Resource nbcr.ucsd.edu.
  Google Scholar
• 21 Druggability Suite for VMD prody.csb.pitt.edu/drugui/.
  Google Scholar
• 22 Yu W, Lakkaraju SK, Raman EP, MacKerell AD Jr. Site-identification by Ligand Competitive Saturation (SILCS) assisted pharmacophore modeling. J. Comput. Aided Mol. Des. 28(5), 491–507 (2014).
  Medline CASGoogle Scholar
• 23 Tan YS, Śledź P, Lang S et al. Using ligand‐mapping simulations to design a ligand selectively targeting a cryptic surface pocket of polo‐like kinase 1. Angew. Chem. 124(40), 10225–10228 (2012).
  Google Scholar
• 24 Tan YS, Spring DR, Abell C, Verma C. The use of chlorobenzene as a probe molecule in molecular dynamics simulations. J. Chem. Inf. Model 54(7), 1821–1827 (2014).
  Medline CASGoogle Scholar
• 25 Yang C-Y, Wang S. Hydrophobic binding hot spots of bcl-xl protein–protein interfaces by cosolvent molecular dynamics simulation. ACS Med. Chem. Lett. 2(4), 280–284 (2011).
  Medline CASGoogle Scholar
• 26 Allen KN, Bellamacina CR, Ding X et al. An experimental approach to mapping the binding surfaces of crystalline proteins. J. Phys. Chem. 100(7), 2605–2611 (1996).
  CASGoogle Scholar
• 27 Mattos C, Ringe D. Locating and characterizing binding sites on proteins. Nat. Biotechnol. 14(5), 595–599 (1996).•• Description of multiple solvent crystal structures and important ideas and observations behind the method.
  Medline CASGoogle Scholar
• 28 Mattos C, Ringe D. Proteins in organic solvents. Curr. Opin. Struct. Biol. 11(6), 761–764 (2001).
  Medline CASGoogle Scholar
• 29 Ringe D, Mattos C. Analysis of the binding surfaces of proteins. Med. Res. Rev. 19(4), 321–331 (1999).
  Medline CASGoogle Scholar
• 30 English AC, Done SH, Caves LSD, Groom CR, Hubbard RE. Locating interaction sites on proteins: the crystal structure of thermolysin soaked in 2% to 100% isopropanol. Proteins 37(4), 628–640 (1999).
  Medline CASGoogle Scholar
• 31 Erlanson DA, McDowell RS, O'Brien T. Fragment-based drug discovery. J. Med. Chem. 47(14), 3463–3482 (2004).
  Medline CASGoogle Scholar
• 32 Nienaber VL, Richardson PL, Klighofer V, Bouska JJ, Giranda VL, Greer J. Discovering novel ligands for macromolecules using X-ray crystallographic screening. Nat. Biotechnol. 18(10), 1105–1108 (2000).
  Medline CASGoogle Scholar
• 33 Mattos C, Bellamacina CR, Peisach E et al. Multiple solvent crystal structures: probing binding sites, plasticity and hydration. J. Mol. Bio. 357(5), 1471–1482 (2006).
  Medline CASGoogle Scholar
• 34 Schwede T. Protein modeling: what happened to the "protein structure gap"? Structure 21(9), 1531–1540 (2013).
  Medline CASGoogle Scholar
• 35 Goodford PJ. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 28(7), 849–857 (1985).• Initial description of GRID.
  Medline CASGoogle Scholar
• 36 Miranker A, Karplus M. Functionality maps of binding sites: a multiple copy simultaneous search method. Proteins 11(1), 29–34 (1991).
  Medline CASGoogle Scholar
• 37 English AC, Groom CR, Hubbard RE. Experimental and computational mapping of the binding surface of a crystalline protein. Protein Eng. 14(1), 47–59 (2001).•• Key comparison of experimental solvent mapping methods to computational solvent mapping using GRID and multiple copy simultaneous search.
  Medline CASGoogle Scholar
• 38 Eisen MB, Wiley DC, Karplus M, Hubbard RE. HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins 19(3), 199–221 (1994).
  Medline CASGoogle Scholar
• 39 Hajduk PJ, Greer J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat. Rev. Drug Discov. 6(3), 211–219 (2007).
  Medline CASGoogle Scholar
• 40 Boobbyer DNA, Goodford PJ, McWhinnie PM, Wade RC. New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure. J. Med. Chem. 32(5), 1083–1094 (1989).
  Medline CASGoogle Scholar
• 41 Wade RC, Clark KJ, Goodford PJ. Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 1. Ligand probe groups with the ability to form two hydrogen bonds. J. Med. Chem. 36(1), 140–147 (1993).
  Medline CASGoogle Scholar
• 42 Cruciani G, Carosati E, Wade RC, Baroni M. Characterization of protein-binding sites and ligands using molecular interaction fields. In: Comprehensive Medicinal Chemistry II. Taylor JB, Triggle DJ (Eds). London, Elsevier, 237–253 (2007).
  Google Scholar
• 43 Carosati E, Sciabola S, Cruciani G. Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field. J. Med. Chem. 47(21), 5114–5125 (2004).
  Medline CASGoogle Scholar
• 44 Cruciani G, Goodford PJ. A search for specificity in DNA-drug interactions. J. Mol. Graph. 12, 116–129 (1994).
  Medline CASGoogle Scholar
• 45 Elber R, Karplus M. Enhanced sampling in molecular dynamics: use of the time-dependent Hartree approximation for a simulation of carbon monoxide diffusion through myoglobin. J. Am. Chem. Soc. 112(25), 9161–9175 (1990).
  CASGoogle Scholar
• 46 Stultz CM, Karplus M. MCSS functionality maps for a flexible protein. Proteins 37(4), 512–529 (1999).
  Medline CASGoogle Scholar
• 47 Schechner M, Sirockin F, Stote RH, Dejaegere AP. Functionality maps of the ATP binding site of DNA gyrase B: generation of a consensus model of ligand binding. J. Med. Chem. 47(18), 4373–4390 (2004).
  Medline CASGoogle Scholar
• 48 Caflisch A. Computational combinatorial ligand design: application to human alpha-thrombin. J. Comput. Aided Mol. Des. 10(5), 372–396 (1996).
  Medline CASGoogle Scholar
• 49 Haider MK, Bertrand H-O, Hubbard RE. Predicting fragment binding poses using a combined MCSS MM-GBSA approach. J. Chem. Inf. Model 51(5), 1092–1105 (2011).
  Medline CASGoogle Scholar
• 50 Haider K, Huggins DJ. Combining solvent thermodynamic profiles with functionality maps of the Hsp90 binding site to predict the displacement of water molecules. J. Chem. Inf. Model 53(10), 2571–2586 (2013).
  Medline CASGoogle Scholar
• 51 Guarnieri F, Mezei M. Simulated annealing of chemical potential: a general procedure for locating bound waters. Application to the study of the differential hydration propensities of the major and minor grooves of DNA. J. Am. Chem. Soc. 118(35), 8493–8494 (1996).
  CASGoogle Scholar
• 52 Guarnieri F, Sarnoff Corporation. Computational protein probing to identify binding sites. US6735530 (2004).
  Google Scholar
• 53 Clark M, Guarnieri F, Shkurko I, Wiseman J. Grand canonical monte carlo simulation of ligand−protein binding. J. Chem. Inf. Model 46(1), 231–242 (2006).
  Medline CASGoogle Scholar
• 54 Kulp JL III, Kulp JL Jr, Pompliano DL, Guarnieri F. Diverse fragment clustering and water exclusion identify protein hot spots. J. Am. Chem. Soc. 133(28), 10740–10743 (2011).
  Medline CASGoogle Scholar
• 55 Dennis S, Camacho CJ, Vajda S. Exploring potential solvation sites of proteins by multistart local minimization. In: Optimization in Computational Chemistry and Molecular Biology. Springer, Boston, MA, USA, 243–261 (2000).
  Google Scholar
• 56 Brenke R, Kozakov D, Chuang G-Y et al. Fragment-based identification of druggable “hot spots” of proteins using Fourier domain correlation techniques. Bioinformatics 25(5), 621–627 (2009).• Initial description of the FTMap/Atlas method and comparison to experimental solvent mapping and known ligands.
  Medline CASGoogle Scholar
• 57 Zhang C, Vasmatzis G, Cornette JL, DeLisi C. Determination of atomic desolvation energies from the structures of crystallized proteins. J. Mol. Bio. 267(3), 707–726 (1997).
  Medline CASGoogle Scholar
• 58 Kortvelyesi T, Dennis S, Silberstein M, Brown L III, Vajda S. Algorithms for computational solvent mapping of proteins. Proteins 51(3), 340–351 (2003).
  Medline CASGoogle Scholar
• 59 Kortvelyesi T, Silberstein M, Dennis S, Vajda S. Improved mapping of protein binding sites. J. Comput. Aided Mol. Des. 17(2–4), 173–186 (2003).
  Medline CASGoogle Scholar
• 60 Dennis S, Kortvelyesi T, Vajda S. Computational mapping identifies the binding sites of organic solvents on proteins. Proc. Natl Acad. Sci. USA 99(7), 4290–4295 (2002).
  Medline CASGoogle Scholar
• 61 Vakser IA, Matar OG, Lam CF. A systematic study of low-resolution recognition in protein–protein complexes. Proc. Natl Acad. Sci. USA 96(15), 8477–8482 (1999).
  Medline CASGoogle Scholar
• 62 Silberstein M, Dennis S, Brown L III, Kortvelyesi T, Clodfelter K, Vajda S. Identification of substrate binding sites in enzymes by computational solvent mapping. J. Mol. Bio. 332(5), 1095–1113 (2003).
  Medline CASGoogle Scholar
• 63 Silberstein M, Damborsky J, Vajda S. Exploring the binding sites of the haloalkane dehalogenase DhlA from Xanthobacter autotrophicus GJ10. Biochemistry 46(32), 9239–9249 (2007).
  Medline CASGoogle Scholar
• 64 Clodfelter KH, Waxman DJ, Vajda S. Computational solvent mapping reveals the importance of local conformational changes for broad substrate specificity in mammalian cytochromes P450. Biochemistry 45(31), 9393–9407 (2006).
  Medline CASGoogle Scholar
• 65 Kozakov D, Brenke R, Comeau SR, Vajda S. PIPER: an FFT‐based protein docking program with pairwise potentials. Proteins 65(2), 392–406 (2006).
  Medline CASGoogle Scholar
• 66 Chuang G-Y, Kozakov D, Brenke R, Comeau SR, Vajda S. DARS (Decoys As the Reference State) potentials for protein–protein docking. Biophys. J. 95(9), 4217–4227 (2008).
  Medline CASGoogle Scholar
• 67 Kozakov D, Hall DR, Chuang G-Y et al. Structural conservation of druggable hot spots in protein–protein interfaces. Proc. Natl Acad. Sci. USA 108(33), 13528–13533 (2011).
  Medline CASGoogle Scholar
• 68 Cencic R, Hall DR, Robert F et al. Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F. Proc. Natl Acad. Sci. USA 108(3), 1046–1051 (2011).
  Medline CASGoogle Scholar
• 69 Zerbe B, Hall DR, Vajda S, Whitty A, Kozakov D. Relationship between hot spot residues and ligand binding hot spots in protein–protein interfaces. J. Chem. Inf. Model 52(8), 2236–2244 (2012).
  Medline CASGoogle Scholar
• 70 Beglov D, Hall DR, Brenke R et al. Minimal ensembles of side chain conformers for modeling protein–protein interactions. Proteins 80(2), 591–601 (2012).
  Medline CASGoogle Scholar
• 71 Grove LE, Hall DR, Beglov D, Vajda S, Kozakov D. FTFlex: accounting for binding site flexibility to improve fragment-based identification of druggable hot spots. Bioinformatics 29(9), 1218–1219 (2013).
  Medline CASGoogle Scholar
• 72 Bohnuud T, Beglov D, Ngan CH et al. Computational mapping reveals dramatic effect of Hoogsteen breathing on duplex DNA reactivity with formaldehyde. Nucl. Acids Res. 40(16), 7644–7652 (2012).
  Medline CASGoogle Scholar
• 73 Beglov D, Roux B. An integral equation to describe the solvation of polar molecules in liquid water. J. Phys. Chem. B. 101(39), 7821–7826 (1997).
  CASGoogle Scholar
• 74 Kovalenko A, Hirata F. Three-dimensional density profiles of water in contact with a solute of arbitrary shape: a RISM approach. Chem. Phys. Lett. 290(1–3), 237–244 (1998).
  CASGoogle Scholar
• 75 Imai T, Oda K, Kovalenko A, Hirata F, Kidera A. Ligand mapping on protein surfaces by the 3D-RISM theory: toward computational fragment-based drug design. J. Am. Chem. Soc. 131(34), 12430–12440 (2009).
  Medline CASGoogle Scholar
• 76 Seco J, Luque FJ, Barril X. Binding site detection and druggability index from first principles. J. Med. Chem. 52(8), 2363–2371 (2009).
  Medline CASGoogle Scholar
• 77 Lexa KW, Carlson HA. Full protein flexibility is essential for proper hot-spot mapping. J. Am. Chem. Soc. 133(2), 200–202 (2010).
  MedlineGoogle Scholar
• 78 Bakan A, Nevins N, Lakdawala AS, Bahar I. Druggability assessment of allosteric proteins by dynamics simulations in the presence of probe molecules. J. Chem. Theory Comput. 8(7), 2435–2447 (2012).
  Medline CASGoogle Scholar
• 79 Guvench O, MacKerell AD Jr. Computational fragment-based binding site identification by ligand competitive saturation. PLoS Comput. Biol. 5(7), e1000435 (2009).
  MedlineGoogle Scholar
• 80 Raman EP, Yu W, Guvench O, MacKerell AD Jr. Reproducing crystal binding modes of ligand functional groups using site-identification by Ligand Competitive Saturation (SILCS) simulations. J. Chem. Inf. Model 51(4), 877–896 (2011).
  Medline CASGoogle Scholar
• 81 Raman EP, Yu W, Lakkaraju SK, MacKerell AD Jr. Inclusion of multiple fragment types in the site-identification by Ligand Competitive Saturation (SILCS) approach. J. Chem. Inf. Model 53(12), 3384–3398 (2013).
  Medline CASGoogle Scholar
• 82 Lakkaraju SK, Raman EP, Yu W, MacKerell AD Jr. Sampling of organic solutes in aqueous and heterogeneous environments using oscillating excess chemical potentials in grand canonical-like monte carlo-molecular dynamics simulations. J. Chem. Theory Comput. 10(6), 2281–2290 (2014).
  Medline CASGoogle Scholar
• 83 Lexa KW, Carlson HA. Improving protocols for protein mapping through proper comparison to crystallography data. J. Chem. Inf. Model 53(2), 391–402 (2013).
  Medline CASGoogle Scholar
• 84 Lexa KW, Goh GB, Carlson HA. Parameter choice matters: validating probe parameters for use in mixed-solvent simulations. J. Chem. Inf. Model 54(8), 2190–2199 (2014).
  Medline CASGoogle Scholar
• 85 Zhou H-X. From induced fit to conformational selection: a continuum of binding mechanism controlled by the timescale of conformational transitions. Biophys. J. 98(6), L15–L17 (2010).
  Medline CASGoogle Scholar
• 86 Csermely P, Palotai R, Nussinov R. Induced fit, conformational selection and independent dynamic segments: an extended view of binding events. Trends Biochem. Sci. 35(10), 539–546 (2010).
  Medline CASGoogle Scholar
• 87 McKay DB. Response. Science 257(5068), 412–413 (1992).
  Medline CASGoogle Scholar
• 88 Arkin MR, Randal M, DeLano WL et al. Binding of small molecules to an adaptive protein–protein interface. Proc. Natl Acad. Sci. USA 100(4), 1603–1608 (2003).
  Medline CASGoogle Scholar
• 89 Thanos CD, Randal M, Wells JA. Potent small-molecule binding to a dynamic hot spot on IL-2. J. Am. Chem. Soc. 125(50), 15280–15281 (2003).
  Medline CASGoogle Scholar
• 90 Hall DR, Grove LE, Yueh C, Ngan CH, Kozakov D, Vajda S. Robust identification of binding hot spots using continuum electrostatics: application to hen egg-white lysozyme. J. Am. Chem. Soc. 133(51), 20668–20671 (2011).• Comparison of MixMD, grand canonical monte carlo and ftmap for finding hot spots on hen egg-white lysozyme.
  Medline CASGoogle Scholar
• 91 Lee EF, Czabotar PE, Smith BJ et al. Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family. Cell Death Differ. 14(9), 1711–1713 (2007).
  Medline CASGoogle Scholar
• 92 Ortiz-Sanchez JM, Nichols SE, Sayyah J, Brown JH, McCammon JA, Grant BJ. Identification of potential small molecule binding pockets on Rho family GTPases. PLoS ONE 7(7), e40809 (2012).
  Medline CASGoogle Scholar
• 93 Labute P. LowModeMD–implicit low-mode velocity filtering applied to conformational search of macrocycles and protein loops. J. Chem. Inf. Model 50(5), 792–800 (2010).
  Medline CASGoogle Scholar
• 94 Damm KL, Carlson HA. Exploring experimental sources of multiple protein conformations in structure-based drug design. J. Am. Chem. Soc. 129(26), 8225–8235 (2007).
  Medline CASGoogle Scholar
• 95 Bohnuud T, Kozakov D, Vajda S. Evidence of conformational selection driving the formation of ligand binding sites in protein–protein interfaces. PLoS Comput. Biol. 10(10), e1003872 (2014).
  MedlineGoogle Scholar
• 96 Ivetac A, McCammon JA. A molecular dynamics ensemble-based approach for the mapping of druggable binding sites. In: Computational Drug Discovery and Design. Baron R (Ed.). Springer New York, USA, 3–12 (2012).
  Google Scholar
• 97 Durrant JD, Hall L, Swift RV, Landon MR, Schnaufer A, Amaro RE. Novel naphthalene-based inhibitors of trypanosoma brucei rna editing ligase 1. PLoS Negl. Trop. Dis. 4(8), doi:10.1371/journal.pntd.0000803 (2010) (Epub ahead of print).
  Google Scholar
• 98 Wassman CD, Baronio R, Demir Ö et al. Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53. Nat. Comms. 4(1407), doi:10.1038/ncomms2361 (2013) (Epub ahead of print).
  MedlineGoogle Scholar
• 99 Park J, Czapla L, Amaro RE. Molecular simulations of aromatase reveal new insights into the mechanism of ligand binding. J. Chem. Inf. Model 53(8), 2047–2056 (2013).
  Medline CASGoogle Scholar
• 100 Ivetac A, McCammon JA. Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach. Chem. Biol. Drug Des. 76(3), 201–217 (2010).
  Medline CASGoogle Scholar
• 101 Grant BJ, Lukman S, Hocker HJ et al. Novel allosteric sites on Ras for lead generation. PLoS ONE 6(10), e25711 (2011).
  Medline CASGoogle Scholar
• 102 Votapka L, Amaro RE. Multistructural hot spot characterization with FTProd. Bioinformatics 29(3), 393–394 (2013).
  Medline CASGoogle Scholar
• 103 Carlson HA, Masukawa KM, McCammon JA. Method for including the dynamic fluctuations of a protein in computer-aided drug design. J. Phys. Chem. A. 103(49), 10213–10219 (1999).
  CASGoogle Scholar
• 104 Johnson DK, Karanicolas J. Druggable protein interaction sites are more predisposed to surface pocket formation than the rest of the protein surface. PLoS Comput. Biol. 9(3), e1002951 (2013).
  Medline CASGoogle Scholar
• 105 Foster TJ, MacKerell AD Jr, Guvench O. Balancing target flexibility and target denaturation in computational fragment‐based inhibitor discovery. J. Comput. Chem. 33(23), 1880–1891 (2012).
  Medline CASGoogle Scholar
• 106 Chuang G-Y, Kozakov D, Brenke R, Beglov D, Guarnieri F, Vajda S. Binding hot spots and amantadine orientation in the influenza a virus M2 proton channel. Biophys. J. 97(10), 2846–2853 (2009).
  Medline CASGoogle Scholar
• 107 Stultz CM, Karplus M. Dynamic ligand design and combinatorial optimization: designing inhibitors to endothiapepsin. Proteins 40(2), 258–289 (2000).
  Medline CASGoogle Scholar
• 108 Miranker A, Karplus M. An automated method for dynamic ligand design. Proteins 23(4), 472–490 (1995).
  Medline CASGoogle Scholar
• 109 Lawrence MC, Davis PC. CLIX: a search algorithm for finding novel ligands capable of binding proteins of known three‐dimensional structure. Proteins 12(1), 31–41 (1992).
  Medline CASGoogle Scholar
• 110 Joseph-McCarthy D, Thomas BE, Belmarsh M, Moustakas D, Alvarez JC. Pharmacophore‐based molecular docking to account for ligand flexibility. Proteins 51(2), 172–188 (2003).
  Medline CASGoogle Scholar
• 111 Carlson HA, Masukawa KM, Rubins K et al. Developing a dynamic pharmacophore model for HIV-1 integrase. J. Med. Chem. 43(11), 2100–2114 (2000).
  Medline CASGoogle Scholar
• 112 Hawkins PCD, Skillman AG, Nicholls A. Comparison of shape-matching and docking as virtual screening tools. J. Med. Chem. 50(1), 74–82 (2007).
  Medline CASGoogle Scholar
• 113 McGann M. FRED pose prediction and virtual screening accuracy. J. Chem. Inf. Model 51(3), 578–596 (2011).
  Medline CASGoogle Scholar
• 114 Brooks BR, Brooks CL, MacKerell AD et al. CHARMM: the biomolecular simulation program. J. Comput. Chem. 30(10), 1545–1614 (2009).
  Medline CASGoogle Scholar
• 115 Ngan CH, Bohnuud T, Mottarella SE et al. FTMAP: extended protein mapping with user-selected probe molecules. Nucl. Acids Res. 40 w271–w275 (2012).
  Medline CASGoogle Scholar
• 116 Schaefer M, Karplus M. A comprehensive analytical treatment of continuum electrostatics. J. Phys. Chem. 100(5), 1578–1599 (1996).
  CASGoogle Scholar
• 117 Yang C-Y, Wang S. Computational analysis of protein hot spots. ACS Med. Chem. Lett. 1(3), 125–129 (2010).
  Medline CASGoogle Scholar